Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0000899243-23-001523

Chief Financial Officer sold 2,658 shares at an average $36.30 ($96,481)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
FRATES JAMES M Chief Financial Officer 2023-01-06 Sale +1,836 $36.08 $66,241 34,831 D
FRATES JAMES M Chief Financial Officer 2023-01-06 Sale +822 $36.79 $30,240 34,009 D
Open-market sales · 2,658 sh · avg $36.30 · $96,481
Loading xslF345X03/doc4.xml…